Talis Biomedical Corporat... (TLIS)
undefined
undefined%
At close: undefined
0.00
-100.00%
After-hours Dec 31, 1969, 07:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue 412.00K 3.65M - 10.94M 3.98M 2.39M
Cost of Revenue 41.00K 8.39M 2.62M - - -
Gross Profit 371.00K -4.74M -2.62M 10.94M 3.98M 2.39M
Operating Income -66.81M -115.14M -191.82M -91.18M -26.70M -21.43M
Interest Income - - - 54.00K 42.00K 93.00K
Pretax Income -62.01M -113.01M -192.04M -91.13M -27.47M -21.34M
Net Income -62.01M -110.89M -190.46M -91.08M -27.43M -21.34M
Selling & General & Admin 28.21M 40.73M 42.42M 13.10M 6.86M 5.43M
Research & Development 40.69M 70.83M 157.59M 89.02M 23.81M 18.39M
Other Expenses -1.72M -1.16M -8.19M -10.94M -3.98M -
Operating Expenses 67.19M 110.40M 191.82M 91.18M 26.70M 21.43M
Interest Expense - - - - - -
Selling & Marketing Expenses - - - - - -
Cost & Expenses 67.23M 118.79M 191.82M 91.18M 26.70M 21.43M
Income Tax - -2.13M -1.58M -54.00K -42.00K 93.00K
Shares Outstanding (Basic) 1.82M 1.78M 1.51M 290.00K 150.00K 150.42K
Shares Outstanding (Diluted) 1.82M 1.78M 1.51M 290.00K 150.00K 150.42K
EPS (Basic) -34.12 -62.45 -126.13 -314.06 -182.88 -141.85
EPS (Diluted) -34.12 -62.45 -126.13 -314.06 -182.88 -141.85
EBITDA -66.05M -106.31M -191.82M -90.42M -25.97M -20.78M
Depreciation & Amortization 770.00K 11.60M 2.62M 1.37M 726.00K 647.00K